Clinical Trial Update: A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 long-term extension study of TAK-385 for endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• TAK-385

Snippet

Sponsor: Takeda | Conditions: Endometriosis | Phase 2 | Status: COMPLETED